Osteoclastogenic-inducing effects of fluoroquinolones on human osteoclast and osteoblast co-cultures
Preprint
- 19 October 2022
- preprint
- Published by Springer Nature in Research Square
Abstract
Fluoroquinolones (FQs) are a broad-spectrum class of antibiotics that may cause some secondary effects in bone tissue, such as delayed fracture healing or osteoarthritis. The aim of this work was to evaluate the effects of five different FQs (ofloxacin, norfloxacin, ciprofloxacin, levofloxacin and moxifloxacin) in osteoclastogenesis, using co-cultures of human osteoclasts and osteoblasts as an in vitro model. It was observed that all FQs, except levofloxacin, promoted an increase in osteoclast formation, gene expression and calcium phosphate resorbing ability, in a dose-dependent manner. MEK and NFkB signaling pathways were involved in cell response, as well as PGE2 production. The observed increase in osteoclastogenesis may be involved in the deleterious effects that FQs may cause in bone tissue.Keywords
All Related Versions
This publication has 33 references indexed in Scilit:
- Fluoroquinolone-Mediated Inhibition of Cell Growth, S-G2/M Cell Cycle Arrest, and Apoptosis in Canine Osteosarcoma Cell LinesPLOS ONE, 2012
- Paracrine-mediated osteoclastogenesis by the osteosarcoma MG63 cell line: is RANKL/RANK signalling really important?Clinical & Experimental Metastasis, 2011
- Concentrations of moxifloxacin in plasma and urine, and penetration into prostatic fluid and ejaculate, following single oral administration of 400mg to healthy volunteersInternational Journal of Antimicrobial Agents, 2008
- Concentration of moxifloxacin in plasma and tonsillar tissue after multiple administration in adult patientsJournal of Antimicrobial Chemotherapy, 2006
- Ciprofloxacin-releasing bioabsorbable polymer is superior to titanium in preventingStaphylococcus epidermidis attachment and biofilm formationin vitroJournal of Biomedical Materials Research Part B: Applied Biomaterials, 2005
- Osteoclast differentiation and activationNature, 2003
- U0126 and PD98059, Specific Inhibitors of MEK, Accelerate Differentiation of RAW264.7 Cells into Osteoclast-like CellsJournal of Biological Chemistry, 2002
- Novel action of quinolones on osteoclast-like cells.The Journal of Toxicological Sciences, 1999
- The Role of Reactive Oxygen Intermediates in Osteoclastic Bone ResorptionBiochemical and Biophysical Research Communications, 1995
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976